LCDR Rebecca D. (Saville) McKinnon, Pharm. D., MS
Regulatory Project Manager, USPHS
Division of Special Pathogen and Transplant Products
OAP/Office of New Drugs/CDER/FDA
10905 New Hampshire Ave., WO22/6191
Silver Spring, MD 20903
LCDR McKinnon is a Pharmacist Officer in the Division of Special Pathogen and Transplant Products, in CDER’s Office of New Drugs. She received a Master’s degree in Microbiology in 1995 and a PharmD in 2001 at the University of Maryland. LCDR McKinnon has been a regulatory project manager for five years in this new drug review division that verifies the safety and efficacy of fluoroquinolone antimicrobials, antifungal, antimycobacterial, antiparasitic, and transplant drug and biologic products. Specifically, she manages and performs regulatory, scientific, legal, and administrative reviews of Investigational New Drug applications, New Drug Applications, and Biologic License Applications for all of the division’s counterterrorism drugs (e.g., products for anthrax, plague, and tularemia). She is the regulatory expert, coordinator, team co-leader, and liaison for all counterterrorism-related issues. Prior to joining the FDA, LCDR McKinnon practiced pharmaceutical care in a community setting and performed research in HIV diagnostics at the University of Maryland Institute for Human Virology.